Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis, JAMA Psychiatry, vol.72, pp.334-341, 2015. ,
Excess mortality of schizophrenia. A meta-analysis, Br J Psychiatry J Ment Sci, vol.171, pp.502-508, 1997. ,
Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis, J Psychiatr Res, vol.102, pp.245-253, 2018. ,
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis, Lancet Psychiatry, vol.4, pp.295-301, 2017. ,
Integrated medical care for patients with serious psychiatric illness: a randomized trial, Arch Gen Psychiatry, vol.58, pp.861-868, 2001. ,
Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis, Br J Psychiatry J Ment Sci, vol.198, pp.434-441, 2011. ,
Life expectancy and cardiovascular mortality in persons with schizophrenia, Curr Opin Psychiatry, vol.25, pp.83-88, 2012. ,
Avoidable mortality in people with schizophrenia or bipolar disorder in England, Acta Psychiatr Scand, vol.127, pp.195-201, 2013. ,
Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study, Eur Psychiatry J Assoc Eur Psychiatr, vol.45, pp.97-103, 2017. ,
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study, Epidemiol Psychiatr Sci, vol.2017, pp.1-9 ,
Mortality associated with depression as compared with other severe mental disorders: a 20-year follow-up study of the GAZEL cohort, J Psychiatr Res, vol.47, pp.851-857, 2013. ,
Mental disorders and access to medical care in the United States, Am J Psychiatry, vol.155, pp.1775-1777, 1998. ,
Prevalence of metabolic syndrome and associated factors in a cohort of individuals with treatment-resistant depression: results from the FACE-DR Study, J Clin Psychiatry, vol.80, 2019. ,
Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis, Psychiatry Res, vol.250, pp.17-24, 2017. ,
Prevalence of underweight in patients with schizophrenia: a meta-analysis, Schizophr Res, vol.195, pp.67-73, 2018. ,
Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis, J Psychopharmacol Oxf Engl, vol.24, pp.69-80, 2010. ,
How sedentary are people with psychosis? A systematic review and meta-analysis, Schizophr Res, vol.171, pp.103-109, 2016. ,
Exercise improves cardiorespiratory fitness in people with schizophrenia: a systematic review and meta-analysis, Schizophr Res, vol.169, pp.453-457, 2015. ,
A systematic review of the benefits of physical therapy within a multidisciplinary care approach for people with schizophrenia: an update, Psychiatry Res, vol.229, pp.828-839, 2015. ,
A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications, J Psychopharmacol Oxf Engl, vol.26, pp.52-61, 2012. ,
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs, Nat Rev Endocrinol, vol.8, pp.114-126, 2011. ,
The iHOPE-20 study: mortality in first episode psychosis-a 20-year follow-up of the Dublin first episode cohort, Soc Psychiatry Psychiatr Epidemiol, 2019. ,
Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis, Br J Psychiatry J Ment Sci, vol.211, pp.339-349, 2017. ,
Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis, JAMA Psychiatry, vol.74, pp.261-269, 2017. ,
Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis, Schizophr Res, vol.208, pp.420-429, 2019. ,
Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study, Schizophr Res, vol.111, pp.9-16, 2009. ,
Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis, J Clin Psychopharmacol, vol.32, pp.309-316, 2012. ,
Is obesity in young people with psychosis a foregone conclusion? Markedly excessive energy intake is evident soon after antipsychotic initiation, Front Psychiatry 9, p.725, 2018. ,
Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients, Schizophr Bull, vol.39, pp.295-305, 2013. ,
Modifiable cardiometabolic risk factors in youth with at-risk mental states: a cross-sectional pilot study, Psychiatry Res, vol.257, pp.424-430, 2017. ,
Short sleep duration is associated with increased obesity markers in European adolescents: effect of physical activity and dietary habits. The HELENA study, Int J Obes, vol.35, pp.1308-1317, 2011. ,
A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls, World Psychiatry, vol.12, pp.240-250, 2013. ,
Cardiometabolic risk factors in young people at ultra-high risk for psychosis: a systematic review and meta-analysis, Schizophr Res, vol.170, pp.290-300, 2016. ,
Prevalence of metabolic syndrome in female and male patients at risk of psychosis, Schizophr Res, vol.181, pp.38-42, 2017. ,
What prevents youth at clinical high risk for psychosis from engaging in physical activity? An examination of the barriers to physical activity, Schizophr Res, vol.201, pp.400-405, 2018. ,
Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis, Psychoneuroendocrinology, vol.39, pp.1-10, 2014. ,
Monitoring of physical health in services for young people at ultra-high risk of psychosis, Early Interv Psychiatry, vol.12, pp.153-159, 2018. ,
Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis, Psychol Med, vol.47, pp.2217-2228, 2017. ,
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis, Lancet Lond Engl, issue.11, 2019. ,
Balancing body and mind: selecting the optimal antipsychotic, Lancet Lond Engl, vol.394, pp.900-902, 2019. ,
Correlates and predictors of antipsychotic drug polypharmacy in real-life settings: Results from a nationwide cohort study, Schizophr Res, 2017. ,
Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects? A cross-sectional study, BMC Psychiatry, vol.11, p.118, 2011. ,
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews, BMC Psychiatry, vol.18, p.275, 2018. ,
Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study, Am J Psychiatry, vol.173, pp.600-606, 2016. ,
Metformin for weight gain associated with second-generation antipsychotics in children and adolescents: a systematic review and meta-analysis, CNS Drugs, vol.32, pp.1103-1112, 2018. ,
Metformin for clozapine associated obesity: a systematic review and meta-analysis, PloS One, vol.11, p.156208, 2016. ,
Combination of metformin and lifestyle intervention for antipsychotic-related weight gain: a meta-analysis of randomized controlled trials, Pharmacopsychiatry, vol.52, pp.24-31, 2019. ,
Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk, Australas Psychiatry Bull R Aust N Z Coll Psychiatr, vol.25, pp.387-390, 2017. ,
Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis, Early Interv Psychiatry, issue.1, 2016. ,
The effectiveness of the keeping the body in Mind Xtend pilot lifestyle program on dietary intake in first-episode psychosis: two-year outcomes, Obes Res Clin Pract, vol.13, pp.214-216, 2019. ,
Reducing weight gain in people with schizophrenia, schizoaffective disorder, and first episode psychosis: describing the process of developing the STructured lifestyle Education for People With SchizophrEnia (STEPWISE) intervention, p.186, 2018. ,
Changes in physical and psychiatric health after a multidisciplinary lifestyle enhancing treatment for inpatients with severe mental illness: the MULTI study I, Schizophr Res, 2018. ,
Exercise as an intervention for first-episode psychosis: a feasibility study, Early Interv Psychiatry, vol.12, pp.307-315, 2018. ,
Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: a pilot study, Schizophr Res, vol.149, pp.112-115, 2013. ,
Nonpharmacological interventions for the treatment of cardiometabolic risk factors in people with schizophrenia-a systematic review, Front Psychiatry, vol.10, p.566, 2019. ,
Clinical determinants of physical activity and sedentary behaviour in individuals with schizophrenia, Asian J Psychiatry, vol.46, pp.62-67, 2019. ,
Intermittent fasting in cardiovascular disorders-an overview, Nutrients, vol.11, 2019. ,
Effects of intermittent fasting on health, aging, and disease, N Engl J Med, vol.381, pp.2541-2551, 2019. ,
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst Rev, vol.7, p.3177, 2018. ,
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia, N Engl J Med, vol.380, pp.11-22, 2019. ,
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial, Arch Gen Psychiatry, vol.67, pp.146-154, 2010. ,
Editorial: is it time to separate EPA from DHA when using omega-3 fatty acids to protect heart and brain?, Curr Opin Clin Nutr Metab Care, vol.23, pp.65-67, 2020. ,
Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: a meta-analysis, JAMA Cardiol, 2019. ,
A Systematic review on the protective effect of N-acetyl cysteine against diabetes-associated cardiovascular complications, Am J Cardiovasc Drugs Drugs Devices Interv, vol.18, pp.283-298, 2018. ,
, What is HeAL. iphys, 2019.
, Algorithm and adaptations. iphys, issue.3, 2019.
To what extent are psychiatrists aware of the comorbid somatic illnesses of their patients with serious mental illnesses? -a cross-sectional secondary data analysis, BMC Health Serv Res, vol.17, p.162, 2017. ,
Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France, Int Psychogeriatr, vol.24, pp.496-502, 2012. ,
, ANSM : Agence nationale de sécurité du médicament et des produits de santé, p.17, 2019.
Effect of a patient's psychiatric history on physicians' estimation of probability of disease, J Gen Intern Med, vol.15, pp.204-206, 2000. ,
Access to primary and specialized somatic health care for persons with severe mental illness: a qualitative study of perceived barriers and facilitators in Swedish health care, BMC Fam Pract, vol.19, 2018. ,
, ALD n o 23 -Schizophrénies. Haute Autorité de Santé, p.17, 2019.
Stress and psychotic transition: a literature review, L'Encephale, vol.42, pp.367-373, 2016. ,
Methylomic changes during conversion to psychosis, Mol Psychiatry, 2016. ,
Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and Queries and Answers Query: Merci de vérifier que les prénoms et les noms ont été correctement identifiés, Answer: oui Query: Nous avons traité la Fig. 3 en Tableau 3 et les figures et tableaux ont été renumérotés. Merci de valider. Answer: oui je valide Query: Merci de nous transmettre la déclaration de liens d'intérêts désormais obligatoire ,
, Query: Merci de compléter la référence [10] en nous fournissant les éléments manquants
, Answer: Increased Cardiovascular Mortality in People With Schizophrenia: A 24-year National Register Study J Westman 1 , S V Eriksson 2 , M Gissler 1, J Hällgren, vol.1
, Mol Psychiatry, vol.27, issue.5, pp.776-794, 2017.
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness, Lancet Psychiatry, vol.6, pp.675-712, 2019. ,
, Consensus statements, 2019.